It’s the last call for entries to the Cambridge Independent Science and Technology Awards 2025. With 15 categories available ...

According to the British newspaper The Telegraph, the scientists behind the Oxford/AstraZeneca COVID-19 vaccine have now developed a vaccine for the plague. Scientists are urging the UK to ...

Logos Capital, Lilly Asia Ventures, and LYFE Capital. The funding will advance Verdiva’s pipeline of next-generation oral and injectable therapies that aim to achieve first-in-class or best-in-class ...

AstraZeneca PLC closed 16.10% below its 52-week high of £133.88, which the company reached on September 3rd.

Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

Invest Ontario is partnering with AstraZeneca (AZN) to expand the company’s global R&D hub in Mississauga. This $820M investment ...

Analyst Andrew Berens of Leerink Partners maintained a Buy rating on AstraZeneca (AZN – Research Report), retaining the price target of ...

Shares of AstraZeneca PLC AZN rallied 1.18% to £111.80 Monday, on what proved to be an all-around positive trading session ...

Tom Keith-Roach, President of AstraZeneca UK, commented, “This is fantastic news for lung cancer patients. These NICE decisions represent another step towards our bold ambition to eliminate cancer as ...

several European countries – led by Austria – had been suspending the roll-out of the AstraZeneca vaccine amid similar fears of adverse side effects. At the time, many people in the UK saw it ...